LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Therapeutics Magenta Therapeutics is actively developing advanced stem cell therapies for a wide range of conditions including blood cancers, genetic diseases, and autoimmune disorders, indicating strong opportunities for biotech and pharmaceutical partners involved in cell therapy and regenerative medicine.

Strategic Mergers The recent merger with Dianthus Therapeutics expands Magenta’s pipeline and market reach; collaborations with companies seeking to integrate innovative biotech solutions could be highly beneficial for business development.

Funding and Growth With over 86 million dollars in private financing and a revenue range of 1 to 10 million dollars, Magenta is in a growth phase, presenting opportunities for investors, service providers, and strategic partners aiming to support emerging biotech innovations.

Pipeline Expansion Magenta's focus on novel targeted conditioning agents like MGTA-117 and CD45 antibody-drug conjugates creates potential sales opportunities for suppliers of specialized biologics, research tools, and clinical development services.

Regulatory Engagement Given the company’s active clinical development and recent regulatory advancements, there are prospects for consultancy and partnership with regulatory service providers to streamline approval processes for cutting-edge stem cell therapies.

Magenta Therapeutics Tech Stack

Magenta Therapeutics uses 8 technology products and services including SiteCatalyst, WP Rocket, Drupal, and more. Explore Magenta Therapeutics's tech stack below.

  • SiteCatalyst
    Analytics
  • WP Rocket
    Caching
  • Drupal
    Content Management System
  • Underscore.js
    Javascript Libraries
  • Akamai Bot Manager
    Security
  • X-XSS-Protection
    Security
  • MediaElement.js
    Video Players
  • Acquia Cloud Site Factory
    Web Hosting

Media & News

Magenta Therapeutics's Email Address Formats

Magenta Therapeutics uses at least 1 format(s):
Magenta Therapeutics Email FormatsExamplePercentage
FLast@magentatx.comJDoe@magentatx.com
50%
FLast@magentatx.comJDoe@magentatx.com
50%

Frequently Asked Questions

What is Magenta Therapeutics's phone number?

Minus sign iconPlus sign icon You can contact Magenta Therapeutics's main corporate office by phone at
+1-857-201-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Magenta Therapeutics's stock symbol?

Minus sign iconPlus sign iconMagenta Therapeutics is a publicly traded company; the company's stock symbol is DNTH.

What is Magenta Therapeutics's official website and social media links?

Minus sign iconPlus sign iconMagenta Therapeutics's official website is magentatx.com and has social profiles on LinkedInCrunchbase.

What is Magenta Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconMagenta Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Magenta Therapeutics have currently?

Minus sign iconPlus sign iconAs of December 2025, Magenta Therapeutics has approximately 51 employees across 1 continents, including North America. Key team members include Vice President Biometrics: J. L.Vice President, Program Leader: S. P.Vp- Head Of Clinical Development: W. S.. Explore Magenta Therapeutics's employee directory with LeadIQ.

What industry does Magenta Therapeutics belong to?

Minus sign iconPlus sign iconMagenta Therapeutics operates in the Biotechnology Research industry.

What technology does Magenta Therapeutics use?

Minus sign iconPlus sign iconMagenta Therapeutics's tech stack includes SiteCatalystWP RocketDrupalUnderscore.jsAkamai Bot ManagerX-XSS-ProtectionMediaElement.jsAcquia Cloud Site Factory.

What is Magenta Therapeutics's email format?

Minus sign iconPlus sign iconMagenta Therapeutics's email format typically follows the pattern of FLast@magentatx.com. Find more Magenta Therapeutics email formats with LeadIQ.

How much funding has Magenta Therapeutics raised to date?

Minus sign iconPlus sign icon As of December 2025, Magenta Therapeutics has raised $86M in funding. The last funding round occurred on May 12, 2021 for $86M.

When was Magenta Therapeutics founded?

Minus sign iconPlus sign iconMagenta Therapeutics was founded in 2016.

Magenta Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

Magenta Therapeutics is a clinical-stage biotechnology company developing medicines to bring the curative power of stem cell transplant to more patients with blood cancers, genetic diseases and autoimmune diseases. Magenta is combining leadership in stem cell biology and biotherapeutics development with clinical and regulatory expertise, a unique business model and broad networks in the stem cell transplant community to revolutionize immune reset for more patients.

Magenta is based in Cambridge, Mass. For more information, please visit www.magentatx.com.

Follow Magenta on Twitter: @magentatx.

Section iconCompany Overview

Phone number
+1-857-201-****
Website
magentatx.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
DNTH
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $86M

    Magenta Therapeutics has raised a total of $86M of funding over 6 rounds. Their latest funding round was raised on May 12, 2021 in the amount of $86M.

  • $1M$10M

    Magenta Therapeutics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $86M

    Magenta Therapeutics has raised a total of $86M of funding over 6 rounds. Their latest funding round was raised on May 12, 2021 in the amount of $86M.

  • $1M$10M

    Magenta Therapeutics's revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    J. L.
    Vice President Biometrics
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. P.
    Vice President, Program Leader
    Phone icon
    Mobile Phone
  • Stylized image of a person
    W. S.
    Vp- Head Of Clinical Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. A.
    Director, Supply Chain
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. S.
    Director Corporate Communications
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    C. G.
    Senior Accountant
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. R.
    Senior Research Associate
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. M.
    Undefined
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. A.
    Executive Assistant
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. S.
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.